Markers and Mechanisms of Macrovascular Disease in IDDM [clinicaltrials:NCT00005474]
Markers and Mechanisms of Macrovascular Disease in IDDM [clinicaltrials:NCT00005474]
Bio2RDF identifier
NCT00005474
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00005474
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
biospec retention [clinicaltrials_vocabulary:biospec-retention]
Samples Without DNA
biospec_descr [clinicaltrials_vocabulary:biospec_descr]
Both DNA samples as well as pl ...... om the
DCCT/EDIC cohort.
brief summary [clinicaltrials_vocabulary:brief-summary]
To elucidate the bioche ...... ent diabetes mellitus (IDDM).
brief title [clinicaltrials_vocabulary:brief-title]
Markers and Mechanisms of Macrovascular Disease in IDDM
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2008-08-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
detailed description [clinicaltrials_vocabulary:detailed-description]
BACKGROUND:
Macr ...... is scheduled to end in 2006.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2000-05-25T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-04-13T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00005474
number of arms [clinicaltrials_vocabulary:number-of-arms]
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2008-08-01T00:00:00Z
reference [clinicaltrials_vocabulary:reference]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
P01HL055782-10
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1996-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2008-08-01T00:00:00Z
identifier
clinicaltrials:NCT00005474
title
Markers and Mechanisms of Macrovascular Disease in IDDM
@en
type
label
Markers and Mechanisms of Macrovascular Disease in IDDM [clinicaltrials:NCT00005474]
@en